ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.12986G>A (p.Arg4329Lys)

gnomAD frequency: 0.00108  dbSNP: rs199560188
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000041101 SCV000064792 likely benign not specified 2012-01-24 criteria provided, single submitter clinical testing Arg4091Lys in exon 45B of TTN: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (12/3118) of African American c hromosomes by the NHLBI Exome Sequencing Project in a broad population (http://e vs.gs.washington.edu/EVS). Arg4091Lys in exon 45B of TTN (allele frequency = 0. 4%, 12/3118) **
GeneDx RCV001703923 SCV000238181 likely benign not provided 2020-03-16 criteria provided, single submitter clinical testing
Ambry Genetics RCV000247432 SCV000320092 likely benign Cardiovascular phenotype 2018-08-14 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Eurofins Ntd Llc (ga) RCV000041101 SCV000333897 likely benign not specified 2015-08-21 criteria provided, single submitter clinical testing
Invitae RCV000472841 SCV000555634 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-25 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000041101 SCV000615990 benign not specified 2016-10-28 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001703923 SCV002049383 likely benign not provided 2021-07-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839821 SCV002100814 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839822 SCV002100815 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839823 SCV002100816 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839820 SCV002100817 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004537141 SCV004721057 likely benign TTN-related disorder 2021-01-27 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Clinical Genetics, Academic Medical Center RCV000041101 SCV001978949 benign not specified no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV001703923 SCV001979860 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.